Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms that are naturally present in many foods and possess a wide range of therapeutic properties. The aim of this paper is to present an overview of the current expanding knowledge of one of the mechanisms by which LAB and other probiotic microorganisms participate in the prevention and treatment of gastrointestinal inflammatory disease through their immune-modulating properties. A special emphasis will be placed on the critical role of the anti-inflammatory cytokine IL-10, and a brief overview of the uses of genetically engineered LAB that produce this important immune response mediator will also be discussed. Thus, this paper will demonstrate the critical role that IL-10 plays in gastrointestinal inflammatory diseases and how probiotics could be used in their treatment.
Importance of IL-10 Modulation by Probiotic Microorganisms in Gastrointestinal Inflammatory Diseases
A. de Moreno de LeBlanc,S. Del Carmen,Meritxell Zurita-Turk,Clarissa Santos Rocha,M. van de Guchte,V. Azevedo,A. Miyoshi,J. LeBlanc
Published 2011 in ISRN Gastroenterology
ABSTRACT
PUBLICATION RECORD
- Publication year
2011
- Venue
ISRN Gastroenterology
- Publication date
2011-02-08
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-99 of 99 references · Page 1 of 1